adenine has been researched along with Hair Diseases in 2 studies
Hair Diseases: Diseases affecting the orderly growth and persistence of hair.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Han, D | 1 |
| Zhang, H | 1 |
| Liu, H | 1 |
| Wong, S | 1 |
| Zhao, N | 1 |
| Qiu, L | 1 |
| Feng, H | 1 |
| Bitar, C | 1 |
| Farooqui, MZ | 1 |
| Valdez, J | 1 |
| Saba, NS | 1 |
| Soto, S | 1 |
| Bray, A | 1 |
| Marti, G | 1 |
| Wiestner, A | 1 |
| Cowen, EW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of PCI-32765 for Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Need Therapy and Are Older Than 65 or Have a 17p Deletion[NCT01500733] | Phase 2 | 86 participants (Actual) | Interventional | 2012-01-05 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The primary endpoint was response after 6 cycles of therapy. Overall response rate was calculated as complete response plus partial response, based on the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2008 criteria.as follows:~Complete response (CR): all group A and group B criteria are met~Group A criteria: resolution of enlarged lymph nodes, normal size spleen and liver, absolute lymphocyte count < 4,000/uL, normocellular bone marrow with < 30% lymphocytes without nodules~Group B criteria: improved blood count (platelet count > 100,000/uL, hemoglobin > 11.0 g/dL, neutrophils > 1,500/uL)~Partial response (PR): at least 2 of the group A criteria plus one of the group B criteria are met~Group A criteria: >=50% decrease in target lymph nodes, >=50% decrease in spleen size, >=50% decrease in liver size, 50% reduction in marrow infiltrates~Group B criteria: platelet count > 100,000/uL, hemoglobin > 11.0 g/dL, neutrophils > 1,500/uL" (NCT01500733)
Timeframe: 6 months
| Intervention | percentage of participants (Number) |
|---|---|
| Elderly Cohort | 93.9 |
| TP53 Cohort | 95.8 |
1 trial available for adenine and Hair Diseases
| Article | Year |
|---|---|
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Agents; Female | 2016 |
1 other study available for adenine and Hair Diseases
| Article | Year |
|---|---|
Morphological analyses and a novel de novo DLX3 mutation associated with tricho-dento-osseous syndrome in a Chinese family.
Topics: Absorptiometry, Photon; Adenine; Adult; Bone Density; China; Conserved Sequence; Craniofacial Abnorm | 2015 |